What should I do if I have other high-risk HPV types?
If you have tested positive for a high-risk human papillomavirus (HPV) type other than HPV 16 or 18—such as HPV 31, 33, 35, 45, 52, or 58—it is important to understand that these genotypes also confer an elevated risk of developing high-grade cervical intraepithelial neoplasia (CIN 2/3) and invasive cervical cancer, though the absolute risk varies by genotype. Management depends on your cytology results (Pap test), colposcopic findings, and prior history. For example, if co-testing (HPV + Pap) shows a high-risk HPV infection with a normal or ASC-US (atypical squamous cells of undetermined significance) Pap result, current U.S. guidelines (e.g., ASCCP 2020 Risk-Based Management Guidelines) recommend either repeat co-testing in 1 year or reflex HPV genotyping—if available—to determine whether HPV 16/18 is present. If HPV 16 or 18 is detected, immediate colposcopy is indicated; if only other high-risk types are identified, management may involve surveillance with co-testing at 1 year, provided no prior high-grade abnormalities exist.
It is essential to recognize that persistent infection with any high-risk HPV type—not just 16 or 18—is the necessary precursor to cervical carcinogenesis. Therefore, follow-up adherence is critical. Colposcopy should be performed if there are abnormal cytologic findings (e.g., LSIL, HSIL), persistent high-risk HPV positivity over multiple testing intervals, or concerning colposcopic impressions—even in the absence of cytologic abnormalities. Vaccination with the 9-valent HPV vaccine (Gardasil 9) remains beneficial for individuals up to age 45 who have not been previously vaccinated, as it covers seven high-risk types (16, 18, 31, 33, 45, 52, 58), potentially preventing new infections and reducing the risk of future disease.
Finally, lifestyle factors—including smoking cessation, consistent condom use, and maintaining optimal immune function—can support viral clearance and reduce progression risk. Always discuss your individual risk profile and screening plan with a gynecologist or healthcare provider trained in cervical cancer prevention.